It makes perfect sense that investors have been fired up about the stocks of companies developing coronavirus vaccines. Several of them have absolutely skyrocketed over the last 12 months.
With two COVID-19 vaccines already on the market in the U.S., is it too late to invest in any of these coronavirus vaccine stocks? I don’t think so. My view is that more gains could be on the way in 2021 for some of the stocks. However, if I could buy only one COVID vaccine stock, it would be Johnson & Johnson (NYSE: JNJ).